S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioventus Inc. stock logo
BVS
Bioventus
$4.55
$4.97
$0.86
$6.08
$360.22M0.5145,279 shs5,751 shs
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
$85.10
+0.3%
$88.82
$74.05
$91.16
$514.00M0.72123,501 shs8,966 shs
The RealReal, Inc. stock logo
REAL
RealReal
$3.15
$2.96
$1.00
$4.10
$333.74M2.993.39 million shs102,866 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioventus Inc. stock logo
BVS
Bioventus
-3.19%-5.41%-15.74%-5.21%+321.30%
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
-0.38%-2.22%-5.26%+0.58%+7.83%
The RealReal, Inc. stock logo
REAL
RealReal
-0.32%-8.96%-7.89%+71.20%+164.71%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bioventus Inc. stock logo
BVS
Bioventus
3.5211 of 5 stars
3.50.00.00.02.54.21.9
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/AN/AN/AN/AN/AN/AN/AN/A
The RealReal, Inc. stock logo
REAL
RealReal
1.1737 of 5 stars
2.22.00.00.02.63.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioventus Inc. stock logo
BVS
Bioventus
3.00
Buy$7.6768.50% Upside
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
0.00
N/A$99.1916.56% Upside
The RealReal, Inc. stock logo
REAL
RealReal
2.33
Hold$3.6114.74% Upside

Current Analyst Ratings

Latest PRSM, BVS, REAL, PPH, and ISX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/12/2024
The RealReal, Inc. stock logo
REAL
RealReal
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$2.30 ➝ $3.70
3/13/2024
Bioventus Inc. stock logo
BVS
Bioventus
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$6.00 ➝ $9.00
3/1/2024
The RealReal, Inc. stock logo
REAL
RealReal
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$6.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioventus Inc. stock logo
BVS
Bioventus
$512.34M0.70$0.77 per share5.94$2.80 per share1.63
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/AN/AN/AN/AN/AN/A
The RealReal, Inc. stock logo
REAL
RealReal
$549.30M0.61N/AN/A($2.97) per share-1.06

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioventus Inc. stock logo
BVS
Bioventus
-$156.23M-$2.52N/A11.38N/A-30.49%2.25%0.62%5/21/2024 (Estimated)
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/AN/A16.59N/AN/AN/AN/AN/A
The RealReal, Inc. stock logo
REAL
RealReal
-$168.47M-$1.67N/AN/AN/A-30.67%N/A-26.38%5/7/2024 (Confirmed)

Latest PRSM, BVS, REAL, PPH, and ISX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
The RealReal, Inc. stock logo
REAL
RealReal
-$0.14N/A+$0.14N/AN/AN/A  
3/12/2024Q4 2023
Bioventus Inc. stock logo
BVS
Bioventus
$0.06$0.07+$0.01$0.24$124.84 million$135.42 million
2/29/2024Q4 2023
The RealReal, Inc. stock logo
REAL
RealReal
-$0.19-$0.15+$0.04-$0.09$142.80 million$143.37 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/A
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
$1.561.83%N/AN/AN/A
The RealReal, Inc. stock logo
REAL
RealReal
N/AN/AN/AN/AN/A

Latest PRSM, BVS, REAL, PPH, and ISX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/28/2024
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
$0.53284/1/20244/2/20244/5/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioventus Inc. stock logo
BVS
Bioventus
1.66
1.53
1.01
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/AN/AN/A
The RealReal, Inc. stock logo
REAL
RealReal
N/A
1.25
1.13

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bioventus Inc. stock logo
BVS
Bioventus
62.94%
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/A
The RealReal, Inc. stock logo
REAL
RealReal
64.73%

Insider Ownership

CompanyInsider Ownership
Bioventus Inc. stock logo
BVS
Bioventus
29.10%
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/A
The RealReal, Inc. stock logo
REAL
RealReal
9.34%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bioventus Inc. stock logo
BVS
Bioventus
97079.17 million56.13 millionNot Optionable
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
147,0006.04 millionN/AOptionable
The RealReal, Inc. stock logo
REAL
RealReal
3,032105.95 million94.91 millionNot Optionable

PRSM, BVS, REAL, PPH, and ISX Headlines

SourceHeadline
The RealReal Stock: Turnaround Strategy Faces A Big Test In 2024The RealReal Stock: Turnaround Strategy Faces A Big Test In 2024
seekingalpha.com - April 19 at 7:48 AM
The RealReal, Inc. (NASDAQ:REAL) Receives $3.61 Average PT from BrokeragesThe RealReal, Inc. (NASDAQ:REAL) Receives $3.61 Average PT from Brokerages
americanbankingnews.com - April 15 at 1:12 AM
UBS Group Raises RealReal (NASDAQ:REAL) Price Target to $3.70UBS Group Raises RealReal (NASDAQ:REAL) Price Target to $3.70
americanbankingnews.com - April 14 at 5:14 AM
The RealReal, Inc. (NASDAQ:REAL) Given Consensus Recommendation of "Hold" by AnalystsThe RealReal, Inc. (NASDAQ:REAL) Given Consensus Recommendation of "Hold" by Analysts
marketbeat.com - April 12 at 10:27 AM
UBS Group Boosts RealReal (NASDAQ:REAL) Price Target to $3.70UBS Group Boosts RealReal (NASDAQ:REAL) Price Target to $3.70
marketbeat.com - April 12 at 8:27 AM
The RealReal Announces Timing of Its First Quarter 2024 Earnings Conference CallThe RealReal Announces Timing of Its First Quarter 2024 Earnings Conference Call
globenewswire.com - April 11 at 4:12 PM
Where To Get Rid of Your Old StuffWhere To Get Rid of Your Old Stuff
msn.com - April 8 at 8:03 PM
How To Mix High and Low Pieces Into Your WardrobeHow To Mix High and Low Pieces Into Your Wardrobe
msn.com - April 5 at 12:27 AM
Louis Vuitton Totes and Dior Micro Bags Can Save LuxuryLouis Vuitton Totes and Dior Micro Bags Can Save Luxury
bloomberg.com - April 5 at 12:27 AM
Man connected to two Worth Avenue jewelry store smash-and-grabs is charged in a thirdMan connected to two Worth Avenue jewelry store smash-and-grabs is charged in a third
palmbeachpost.com - April 5 at 12:27 AM
Dominic Burgess Talks ‘Palm Royale,’ His Sex Scene With Kim Kardashian on ‘AHS’ and How a Failed ‘iCarly’ Audition Led to His Big BreakDominic Burgess Talks ‘Palm Royale,’ His Sex Scene With Kim Kardashian on ‘AHS’ and How a Failed ‘iCarly’ Audition Led to His Big Break
yahoo.com - April 5 at 12:27 AM
What is the Best Site to Sell Clothes on: Top 5 OptionsWhat is the Best Site to Sell Clothes on: Top 5 Options
albawaba.com - April 3 at 5:40 PM
What Happened to the Wrap Dress?What Happened to the Wrap Dress?
nytimes.com - April 2 at 4:38 PM
The RealReal, Inc. (NASDAQ:REAL) Sees Significant Increase in Short InterestThe RealReal, Inc. (NASDAQ:REAL) Sees Significant Increase in Short Interest
marketbeat.com - April 1 at 8:31 AM
The History Behind the Iconic Hermès Kelly BagThe History Behind the Iconic Hermès Kelly Bag
msn.com - April 1 at 4:36 AM
Six Ways to Wear Brown, Inspired by the RunwaysSix Ways to Wear Brown, Inspired by the Runways
wmagazine.com - March 29 at 5:04 PM
ThredUp Releases Resale State of the UnionThredUp Releases Resale State of the Union
uk.movies.yahoo.com - March 28 at 1:32 PM
The RealReal, Inc.: The RealReal Earnings: Restructuring Lessens Risk of Debt Default or a Dilutive Equity RaiseThe RealReal, Inc.: The RealReal Earnings: Restructuring Lessens Risk of Debt Default or a Dilutive Equity Raise
finance.yahoo.com - March 28 at 3:31 AM
Mercari drops seller feesMercari drops seller fees
axios.com - March 27 at 10:31 PM
The Global Secondhand Market Grew Faster Than Traditional Retail Last Year, According to ThredUp’s Annual ReportThe Global Secondhand Market Grew Faster Than Traditional Retail Last Year, According to ThredUp’s Annual Report
yahoo.com - March 27 at 12:31 PM
These are the best-performing ‘Big Short” Michael Burry stocks of 2024These are the best-performing ‘Big Short” Michael Burry stocks of 2024
finbold.com - March 26 at 9:09 AM
This ‘Palm Royale’-Inspired Edit on The RealReal Is Full of Vintage Dior, Gucci and Hermés — And It’s Almost All on SaleThis ‘Palm Royale’-Inspired Edit on The RealReal Is Full of Vintage Dior, Gucci and Hermés — And It’s Almost All on Sale
yahoo.com - March 20 at 5:32 PM
Unknown Michael Burry stock up 200% in the last yearUnknown Michael Burry stock up 200% in the last year
finbold.com - March 20 at 7:17 AM
eBay’s New Consignment Service Wants Help You Offload Your LuxuryeBay’s New Consignment Service Wants Help You Offload Your Luxury
robbreport.com - March 18 at 7:18 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bioventus logo

Bioventus

NYSE:BVS
Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.
VanEck Pharmaceutical ETF logo

VanEck Pharmaceutical ETF

NASDAQ:PPH
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
RealReal logo

RealReal

NASDAQ:REAL
The RealReal, Inc. operates an online marketplace for resale luxury goods in the United State. The company offers various product categories, including women's fashion, men's fashion, jewelry, and watches. It primarily sells products through online marketplace and retail stores. The company was incorporated in 2011 and is headquartered in San Francisco, California.